Washington Research Foundation Awards $275K to Support David Koelle’s Development of Herpes Vaccine at University of Washington

Washington Research Foundation (WRF) has awarded a $275,000 technology commercialization grant to Dr. David Koelle, a professor of Medicine and Laboratory Medicine & Pathology at the University of Washington. The funding will support the continued development of a novel messenger RNA therapeutic vaccine aimed at improving treatment options for patients with genital herpes. This follows a previous $100,000 grant from WRF in 2024 that supported early-stage research on the project.